Psychedelics Today

In this episode, Kyle sits down with Dylan Beynon, founder of Mindbloom, NYC based mental health and wellbeing platform. In the show they talk about how Mindbloom differs from other centers, paving the way for accessibility and affordability. 3 Key Points: Mindbloom is a next-generation mental health platform, catered to accessibility and affordability. They use ketamine tablets, different from lozenges and any other method. The tablets are held in the mouth and then spit out to avoid entering the liver, causing a sedation-like experience. Mindbloom differentiates themselves from other psychedelic therapy options by using a patient-choice model, to keep it affordable for those who need it. They offer the 4-week therapy model and give patients the option to choose ‘add-ons’ like extra integration.  Support the show Patreon Leave us a review on iTunes Share us with your friends – favorite podcast, etc Join our Facebook group - Psychedelics Today group – Find the others and create community. Navigating